Esperion Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
ESPR Key Statistics
Stock Snapshot
With a market cap of 523.89M, Esperion Therapeutics(ESPR) trades at $2.05. The stock has a price-to-earnings ratio of -9.79.
As of 2026-04-17, Esperion Therapeutics(ESPR) stock has fluctuated between $2.03 and $2.22. The current price stands at $2.05, placing the stock +1.0% above today's low and -7.6% off the high.
The Esperion Therapeutics(ESPR)'s current trading volume is 7.93M, compared to an average daily volume of 8.66M.
In the last year, Esperion Therapeutics(ESPR) shares hit a 52-week high of $4.18 and a 52-week low of $0.69.
In the last year, Esperion Therapeutics(ESPR) shares hit a 52-week high of $4.18 and a 52-week low of $0.69.
ESPR News
Analyst Serge Belanger from Needham maintained a Buy rating on Esperion and keeping the price target at $5.00. Unlock hedge fund-level data and powerful invest...
Analyst ratings
71%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.